Alps Advisors Inc Legend Biotech Corp Transaction History

Alps Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$41.14 - $56.98 $7.29 Million - $10.1 Million	-177,274 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$35.31 - $50.56 $18,467 - $26,442	-523 Reduced 0.29%	177,274 $8.96 Million
Q2 2021 Aug 11, 2021	SELL	$25.8 - $41.09 $1.57 Million - $2.51 Million	-61,033 Reduced 25.55%	177,797 $7.3 Million
Q1 2021 May 07, 2021	BUY	$23.55 - $32.4 $5,369 - $7,387	228 Added 0.1%	238,830 $6.93 Million
Q4 2020 Feb 03, 2021	BUY	$25.8 - $32.39 $6.16 Million - $7.73 Million	238,602 New	238,602 $6.72 Million

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.49B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.